Buscar
Kenvue Inc
KVUEAñadir a la lista de seguimiento
18.960USD
+0.160+0.85%
Cierre 06/25, 16:00（ET）Cotizaciones retrasadas 15 min
36.40BCap. mercado
22.42P/E TTM
Más Datos de Kenvue Inc Compañía
Kenvue Inc. is a consumer health company. The Company’s differentiated portfolio of brands includes Tylenol, Neutrogena, Listerine, Johnson’s, BAND-AID, Aveeno, Zyrtec, and Nicorette. It operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. Its Self Care product categories include pain care; cough, cold, and allergy; digestive health; smoking cessation; eye care; and other products. Self Care segments include brands such as Tylenol, Motrin, Nicorette, Benadryl, Zyrtec, Zarbee’s, ORSLTM, Rhinocort, and Calpol. The Skin Health and Beauty segment is focused on face and body care, as well as hair, sun, and other products. The Essential Health segment includes oral care, baby care, women’s health, wound care, and other products. Its portfolio includes Self Care, Skin Health and Beauty, and Essential Health products which connect with consumers across North America, Asia Pacific (APAC), Europe, Middle East, and Africa (EMEA), and Latin America (LATAM).
Información de Kenvue Inc
Símbolo de cotizaciónKVUE
Nombre de la empresaKenvue Inc
Fecha de salida a bolsaMay 04, 2023
Director ejecutivoPerry (Kirk L)
Número de empleados22000
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 04
Dirección1 Kenvue Way
CiudadSUMMIT
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07901
Teléfono19088741200
Sitio Webhttps://www.kenvue.com
Símbolo de cotizaciónKVUE
Fecha de salida a bolsaMay 04, 2023
Director ejecutivoPerry (Kirk L)
Ejecutivos de Kenvue Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
111.42K
+12.47%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
93.62K
+8.09%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
76.92K
+18.68%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
61.45K
+28.19%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
61.41K
+7.07%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
40.94K
--
Mr. Michael E. Sneed
Mr. Michael E. Sneed
Independent Director
Independent Director
37.10K
+70.93%
Mr. Jan Meurer
Mr. Jan Meurer
Group President, North America
Group President, North America
33.18K
+13.30%
Ms. Charmaine England
Ms. Charmaine England
Chief Growth Officer
Chief Growth Officer
29.06K
+5.38%
Ms. Melanie L. Healey
Ms. Melanie L. Healey
Independent Director
Independent Director
26.47K
+99.43%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Carlton Lawson
Mr. Carlton Lawson
Group President, Europe, Middle East and Africa and Latin America
Group President, Europe, Middle East and Africa and Latin America
111.42K
+12.47%
Ms. Meredith (Meri) Stevens
Ms. Meredith (Meri) Stevens
Chief Operations Officer
Chief Operations Officer
93.62K
+8.09%
Mr. Kirk L. Perry
Mr. Kirk L. Perry
Chief Executive Officer, Director
Chief Executive Officer, Director
76.92K
+18.68%
Dr. Caroline Tillett
Dr. Caroline Tillett
Chief Scientific Officer
Chief Scientific Officer
61.45K
+28.19%
Ms. Luani Alvarado
Ms. Luani Alvarado
Chief People Officer
Chief People Officer
61.41K
+7.07%
Mr. Larry J. Merlo
Mr. Larry J. Merlo
Independent Chairman of the Board
Independent Chairman of the Board
40.94K
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Kenvue Inc?
Los cinco principales accionistas de Kenvue Inc son: Mr. Carlton Lawson
¿Cuántas instituciones poseen acciones de Kenvue Inc (KVUE)?
A fecha de 2026Q1, 2195 instituciones poseen acciones de Kenvue Inc, con un valor de mercado combinado de aproximadamente 1.82B, lo que representa el 94.75% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -195892523.00.
¿Cuál es la mayor fuente de ganancias de Kenvue Inc?
El 2026Q1, el segmento empresarial Face and Body Care generó la ganancia más alta para Kenvue Inc, ascendiendo a 2.87B y representando el 19.00% de la ganancia total.
